| Pomegranate fruit as a rich source of biologically active compounds S Sreekumar, H Sithul, P Muraleedharan, JM Azeez, S Sreeharshan BioMed research international 2014, 2014 | 318 | 2014 |
| In vitro estrogenic activities of fenugreek Trigonella foenum graecum seeds S Sreeja, VS Anju Indian Journal of Medical Research 131 (6), 814-819, 2010 | 136 | 2010 |
| An in vitro study on antiproliferative and antiestrogenic effects of Boerhaavia diffusa L. extracts S Sreeja, S Sreeja Journal of ethnopharmacology 126 (2), 221-225, 2009 | 102 | 2009 |
| Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation S Sreeja, TRS Kumar, BS Lakshmi, S Sreeja The Journal of nutritional biochemistry 23 (7), 725-732, 2012 | 82 | 2012 |
| Copper-67-labeled bombesin peptide for targeted radionuclide therapy of prostate cancer TT Huynh, EM van Dam, S Sreekumar, C Mpoy, BJ Blyth, F Muntz, ... Pharmaceuticals 15 (6), 728, 2022 | 19 | 2022 |
| Differential regulation and targeting of estrogen receptor α turnover in invasive lobular breast carcinoma S Sreekumar, KM Levine, MJ Sikora, J Chen, N Tasdemir, D Carter, ... Endocrinology 161 (9), bqaa109, 2020 | 18 | 2020 |
| Controlled three-dimensional tumor microenvironments recapitulate phenotypic features and differential drug response in early vs advanced stage breast cancer M Singh, H Venkata Krishnan, S Ranganathan, B Kiesel, JH Beumer, ... ACS Biomaterials Science & Engineering 4 (2), 421-431, 2018 | 17 | 2018 |
| Progesterone regulates the proliferation of breast cancer cells–in vitro evidence JM Azeez, H Sithul, I Hariharan, S Sreekumar, J Prabhakar, S Sreeja, ... Drug design, development and therapy, 5987-5999, 2015 | 17 | 2015 |
| The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor AJ Casa, D Hochbaum, S Sreekumar, S Oesterreich, AV Lee Molecular and Cellular Endocrinology 415, 76-86, 2015 | 17 | 2015 |
| Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges MM Boisen, CL Andersen, S Sreekumar, AM Stern, S Oesterreich Molecular and Cellular Endocrinology 418, 322-333, 2015 | 11 | 2015 |
| Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer KA Lofgren, S Sreekumar, EC Jenkins Jr, KJ Ernzen, PA Kenny Antibody Therapeutics 4 (4), 252-261, 2021 | 10 | 2021 |
| Preclinical efficacy of a PARP-1 targeted Auger-emitting radionuclide in prostate cancer S Sreekumar, D Zhou, C Mpoy, E Schenk, J Scott, JM Arbeit, J Xu, ... International journal of molecular sciences 24 (4), 3083, 2023 | 9 | 2023 |
| Therapeutic Efficacy of 177Lu-Labeled A20FMDV2 Peptides Targeting ανβ6 TT Huynh, S Sreekumar, C Mpoy, BE Rogers Pharmaceuticals 15 (2), 229, 2022 | 7 | 2022 |
| Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation S Sreekumar, SK TR, S Sreeharshan The Journal of nutritional biochemistry 23 (7), 725-732, 2012 | 6 | 2012 |
| Pilot study: PARP1 imaging in advanced prostate cancer F Dehdashti, MA Reimers, KI Shoghi, DL Chen, J Luo, B Rogers, ... Molecular Imaging and Biology 24 (6), 853-861, 2022 | 4 | 2022 |
| A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6 TT Huynh, S Sreekumar, C Mpoy, BE Rogers Oncotarget 13, 360, 2022 | 3 | 2022 |
| Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations BM Parsons, DR Meier, S Sreekumar, CS Richmond, KJ Ernzen, ... Cancer Research 79 (13_Supplement), 1317-1317, 2019 | 2 | 2019 |
| Abstract P4-05-02: Differential regulation of ER protein-turnover in invasive lobular carcinoma cells RC Jankowitz, S Sreekumar, KM Levine, C Meier, MJ Sikora, A Basudan, ... Cancer Research 78 (4_Supplement), P4-05-02-P4-05-02, 2018 | 2 | 2018 |
| Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate KA Lofgren, NC Reker, S Sreekumar, PA Kenny Antibody Therapeutics 5 (3), 226-231, 2022 | 1 | 2022 |
| Abstract PD7-02: Novel human cell line xenograft models of ERα-positive metastatic invasive lobular breast carcinoma as pre-clinical platforms for validating candidate genetic … N Tasdemir, J Scott, J Laotche, W Hou, EA Bossart, J Atkinson, G Sflomos, ... Cancer Research 79 (4_Supplement), PD7-02-PD7-02, 2019 | 1 | 2019 |
